Peter Wikström
Impact in
- Cancer Research top 10%
- Protease and Inhibitor Mechanisms
- Hematology top 10%
- Blood Coagulation and Thrombosis Mechanisms
Papers in
-
- Protease and Inhibitor Mechanisms 9
- Oncology 13
- Peptidase Inhibition and Analysis 13
- Co-authors
- Emily V. Shaw (10 shared papers)Elliott N. Shaw (6 shared papers)Robert W. Mason (2 shared papers)Herbert Angliker (7 shared papers)Jörg Stürzebecher (7 shared papers)Cynthia A. Crawford (1 shared paper)Heidrun Kirschke (3 shared papers)Dagmar Prasa (3 shared papers)
- Journals
- Biochemical Journal (9 papers)Archives of Biochemistry and Biophysics (2 papers)FEBS Letters (2 papers)Analytical Biochemistry (1 paper)Bioorganic & Medicinal Chemistry Letters (1 paper)
- Partner nations
- SwitzerlandGermanyUnited States
In The Last Decade
Peter Wikström
25 papers receiving 814 citations
Peers
Comparison fields: 5 of 74
- Cancer Research 285
- Hematology 148
- Oncology 321
- Cell Biology 157
- Immunology and Allergy 38
Countries citing papers authored by Peter Wikström
This map shows the geographic impact of Peter Wikström's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Wikström with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Wikström more than expected).
Fields of papers citing papers by Peter Wikström
This network shows the impact of papers produced by Peter Wikström. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Wikström. The network helps show where Peter Wikström may publish in the future.
Co-authors
The 25 scholars most cited alongside Peter Wikström, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 25 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1988 | 132 | |
| 2 | 1997 | 93 | |
| 3 | 1989 | 81 | |
| 4 | 1988 | 58 | |
| 5 | 1993 | 57 | |
| 6 | 1989 | 57 | |
| 7 | 1999 | 50 | |
| 8 | 1983 | 48 | |
| 9 | 1987 | 42 | |
| 10 | 1990 | 36 | |
| 11 | 1989 | 31 | |
| 12 | 1985 | 30 | |
| 13 | 1988 | 29 | |
| 14 | 1999 | 23 | |
| 15 | 1991 | 22 | |
| 16 | 1995 | 20 | |
| 17 | 1992 | 16 | |
| 18 | 1988 | 15 | |
| 19 | Peptidyl fluoromethyl ketones as thiol protease inhibitors. | 1986 | 14 |
| 20 | 1989 | 14 |
About Peter Wikström
Peter Wikström is a scholar working on Cancer Research, Oncology, Hematology, Molecular Biology and Biotechnology, having authored 25 papers that have together received 902 indexed citations. Recurring topics across this work include Peptidase Inhibition and Analysis (13 papers), Protease and Inhibitor Mechanisms (9 papers), Biochemical and Structural Characterization (5 papers), Chemical Synthesis and Analysis (4 papers), Blood Coagulation and Thrombosis Mechanisms (4 papers), Calpain Protease Function and Regulation (3 papers), Chemical synthesis and pharmacological studies (2 papers) and Monoclonal and Polyclonal Antibodies Research (2 papers). The work is most often cited by research in Cancer Research (285 citations), Hematology (148 citations), Oncology (321 citations), Cell Biology (157 citations) and Immunology and Allergy (38 citations). Peter Wikström has collaborated with scholars based in Switzerland, Germany and United States. Frequent co-authors include Emily V. Shaw, Elliott N. Shaw, Robert W. Mason, Herbert Angliker, Jörg Stürzebecher, Cynthia A. Crawford, Heidrun Kirschke, Dagmar Prasa, Jörg Hauptmann and Stuart R. Stone. Their work appears in journals such as Biochemical Journal, Archives of Biochemistry and Biophysics, FEBS Letters, Analytical Biochemistry and Bioorganic & Medicinal Chemistry Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.